Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of Lutetium Lu-177 and ABY-271 in Patients with HER2-Positive Metastatic Breast Cancer
GermanyStudy on Inhaled Molgramostim for Children with Autoimmune Pulmonary Alveolar Proteinosis
GermanyStudy on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant
GermanyStudy on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease
GermanyStudy of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation
GermanyStudy on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients
GermanyStudy Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide
GermanyStudy of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer
GermanyStudy Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells
GermanyStudy of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
GermanyStudy on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies
GermanyStudy on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer's Disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
